SITC EU-IO Drug Development Summit

This is a two‑day meeting bringing together stakeholders from academia, industry, and clinical research to discuss current topics in immuno‑oncology drug development. The programme covers emerging therapeutic modalities, clinical and regulatory considerations, and perspectives on advancing new immuno‑oncology therapies in Europe.

More information on the event, pricing, and registration is available by the link above.